AIToday
Top Companies' AI MovesTop Companies AIPublished: Jun 13, 2026, 06:30 JST

SanDisk and Western Digital shares jump 6% as AI storage demand drives record highs, with SanDisk up 724% year-to-date on strong datacenter revenue.

SanDisk and Western Digital shares jump 6% as AI storage demand drives record highs, with SanDisk up 724% year-to-date on strong datacenter revenue.

3 Key Points

  1. What happened

    SanDisk (NASDAQ: SNDK) and Western Digital (NASDAQ: WDC) both rose 6% on Friday, with SNDK trading near $1,989 and WDC near $561. SanDisk has surged 724% year-to-date and 4,638% over the past 12 months, while Western Digital has gained 224% year-to-date and 902% over the past year, riding demand for AI infrastructure storage.

  2. Why it matters

    SanDisk's Q3 FY2026 results (reported April 30) showed revenue of $5.95 billion(約9500億円), up 251% year-over-year, with datacenter segment revenue jumping 645% year-over-year to $1.47 billion(約2400億円). CEO David Goeckeler called the quarter "a fundamental inflection point for SanDisk" as the company shifts toward datacenter customers under multi-year supply contracts. Western Digital's Q3 FY2026 report delivered revenue of $3.34 billion(約5300億円), up 46% year-over-year, with non-GAAP gross margin clearing 50% for the first time in recent memory as AI workloads tightened hard-disk drive supply.

  3. What to watch

    SanDisk guided Q4 FY2026 revenue to $7.75 billion(約1.2兆円) to $8.25 billion(約1.3兆円) and non-GAAP EPS of $30 to $33. Western Digital guided Q4 FY2026 revenue to roughly $3.65 billion(約5800億円) and non-GAAP EPS of $3.25, plus or minus $0.15. The market is debating whether this represents the early innings of a multi-year AI memory supercycle or a late-stage rally vulnerable to sharp reversal; incoming NAND and hard-disk drive pricing data could test the rally.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Top Companies AIRead Original Article

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleTakeda Pharmaceutical's oral immunology candidate Zasochtinib showed statistical superiority over a competing therapy in a Phase 3 trial for moderate-to-severe plaque psoriasis, bolstering the company's late-stage pipeline story, though the company simultaneously scaled back a planned equity offering.